Search Results - "Pecherina, T. B."

Modern ways to reduced mortality of myocardial infarction. What should be done? by Barbarash, O. L., Pecherina, T. B.

“…Myocardial infarction is a formidable manifestation of coronary artery disease and accounts for one third of deaths associated with coronary disease. In…”
Get full text

Antifibrotic effects of sodium-glucose cotransporter 2 inhibitors in patients with heart failure by Ignatova, Yu. S., Shuster, S. U., Pecherina, T. B., Barbarash, O. L.

“…Heart failure (HF) is an urgent public health problem worldwide. A fundamental role in HF progression is played by fibrosis, which causes structural myocardial…”
Get full text

Biomarkers of myocardial fibrosis and their genetic regulation in patients with heart failure by Pecherina, T. B., Kutikhin, A. G.

“…Currently, the development of chronic heart failure (CHF) is considered from the perspective of pathological structural remodeling of myocardium and fibrosis…”
Get full text

Type 2 myocardial infarction: the potential for early detection by Karetnikova, V. N., Motova, A. V., Osokina, A. V., Golubovskaia, D. P., Oleinik, I. R., Schmidt, E. A., Zhidkova, I. I., Pecherina, T. B., Polikutina, O. M., Barbarash, O. L.

“…Aim . To evaluate the potential of using factors associated with type 2 myocardial infarction (MI) for its early diagnosis. Material and methods . This…”
Get full text

In Search of Optimal Criteria for Iron Deficiency in CHF Patients. Post-hoc Analysis of the Study "Prevalence of Iron Deficiency in Patients With Chronic Heart Failure in the Russian Federation (ID-CHF-RF)" by Mareev, V Yu, Mareev, Yu V, Kobalava, Zh D, Begrambekova, Yu L, Karapetyan, L V, Galochkin, S A, Kazakhmedov, E R, Lapshin, A A, Garganeeva, A A, Kuzheleva, E A, Efremushkina, A A, Kiseleva, E V, Barbarash, O L, Pecherina, T B, Galyavich, A S, Galeeva, Z M, Baleeva, L V, Koziolova, N A, Veclich, A S, Duplyakov, D V, Maksimova, M N, Yakushin, S S, Smirnova, E A, Sedykh, E V, Shaposhnik, I I, Makarova, N A, Zemlyanukhina, A A, Skibitsky, V V, Fendrikova, A V, Skibitsky, A V, Spiropoulos, N A, Seredenina, E M, Orlova, Ya A, Eruslanova, K A, Kotovskaya, Yu V, Tkacheva, O N, Fedin, M A

“…Comparative analysis of clinical, anamnestic, and laboratory and instrumental data of patients with chronic heart failure (CHF) and iron deficiency (ID)…”
Get more information

Genetic Predisposition to Early Myocardial Infarction by Goncharova, I. A., Nazarenko, M. S., Babushkina, N. P., Markov, A. V., Pecherina, T. B., Kashtalap, V. V., Tarasenko, N. V., Ponasenko, A. V., Barbarash, O. L., Puzyrev, V. P.

“…The aim of the study was to identify the features of the genetic structure of myocardial infarction (MI) susceptibility depending on age (“early MI” denoting…”
Get full text

Iron deficiency in Russia heart failure patients. Observational cross-sectional multicenter study by Mareev, V Yu, Begrambekova, Yu L, Mareev, Yu V, Kobalava, Zh D, Karapetyan, L V, Galochkin, S A, Kazakhmedov, E R, Lapshin, A A, Garganeeva, A A, Kuzheleva, E A, Efremushkina, A А, Kiseleva, E V, Barbarash, O L, Pecherina, T B, Galyavich, A S, Galeeva, Z M, Baleeva, L V, Koziolova, N A, Veklich, A S, Duplyakov, D V, Maksimova, M N, Yakushin, S S, Smirnova, E A, Sedykh, E V, Shaposhnik, I I, Makarova, N A, Zemlyanukhina, A A, Skibitsky, V V, Fendrikova, A V, Skibitsky, A V, Spiropulos, N A, Seredenina, E M, Orlova, Ya A, Eruslanova, K A, Kotovskaya, Yu V, Tkacheva, O N, Fedin, M A

“…Aim    To evaluate the prevalence of iron deficiency (ID) in Russian patients with heart failure (HF).Material and methods    Iron metabolism variables were…”
Get more information

Participation of the C-terminal propeptide procollagen type I in the formation of cardiofibrosis in patients with myocardial infarction with preserved left ventricular ejection fraction by Osokina, A. V., Karetnikova, V. N., Polikutina, O. M., Ivanova, A. V., Pecherina, T. B., Gruzdeva, O. V., Dyleva, Yu. A., Kokov, A. N., Brel, N. K., Barbarash, O. L.

“…Aim. To study the dynamics of procollagen type I carboxy-terminal propeptide (PICP) with an assessment of potential associations with cardiac fibrosis (CF) and…”
Get full text

Actual Issues of Ischemic and Hemorrhagic Events Risk Management During Antithrombotic Therapy in Patients with Acute Coronary Syndrome by Velieva, R. M., Pecherina, T. B., Vorobiev, A. S., Kashtalap, V. V., Sedykh, D. Yu

“…Today, optimal duration of double antiplatelet (DAPT) and triple antithrombotic therapy (TATT) in patients with acute coronary syndrome (ACS) remains the…”
Get full text

Predictors of myocardial fibrosis and loss of epicardial adipose tissue volume in the long-term period after myocardial infarction by Barbarash, O. L., Gruzdeva, O. V., Pecherina, T. B., Akbasheva, O. E., Borodkina, D. A., Kashtalap, V. V., Karetnikova, V. N., Kokov, A. N., Brel, N. K., Dyleva, Yu. A., Belik, E. V., Uchasova, E. G., Bychkova, E. E., Kuzmina, A. A.

“…Aim. To assess the changes of biochemical markers in hospitalization, the relationship with the severity of myocardial fibrosis and the epicardial adipose…”
Get full text

Fibrogenesis Genes and Susceptibility to Coronary Atherosclerosis by Goncharova, I A, Pecherina, T B, Markov, A V, Kashtalap, V V, Tarasenko, N V, Puzyrev, V P, Barbarash, O L

“…To study associations between genes of different functional classes, including fibrogenesis genes, with coronary atherosclerosis and specific features of its…”
Get more information

The role of matrix metalloproteinases in assessment of prognosis in patients with ST-elevation myocardial infarction during hospital stay by Pecherina, T B, Gruzdeva, O V, Kashtalap, V V, Barbarash, O L

“…Aim of the study was to investigate role of matrix metalloproteinases (MMP) in assessment of prognosis of repetitive cardiovascular events during hospital stay…”
Get more information

Postregistration study of comparative assessment efficacy of the use of fixed combination of nebivolol and amlodipine for the treatment of patients with moderate and high degree of arterial hypertension by Pecherina, T B, Vedernikova, A G, Evdokimov, D O, Klimenkova, A V, Barbarash, O L

“…of the study was to assess efficacy of the use of fixed combination of nebivolol and amlodipine in patients with moderate and high degree of arterial…”
Get more information

Otsenka klinicheskoy znachimosti matriksnoy metalloproteinazy-9 pri infarkte miokarda s pod\"emom segmenta ST, oslozhnennom ostroy serdechnoy nedostatochnost'yu by T. B Pecherina, V. V Kashtalap, O. L Barbarash

“…В последние годы актуальным остается поиск новых биологических маркеров, позволяющих оценить риск развития сердечной недостаточности у больных в остром периоде…”
Get full text

Clinical and anamnestic characteristics of patients depending on left ventricular ejection fraction: results of a register study by Parfenov, P. G., Yurkina, A. V., Golubovskaya, D. P., Shuster, S. Y., Dren, E. V., Guselnikova, Y. I., Lebedeva, N. B., Pecherina, T. B.

“…Aim . To study the clinical and anamnestic features of patients followed up in the Center for Chronic Heart Failure at the Regional Vascular Center according…”
Get full text

P5303Relationship of the dynamics of serum collagen and epicardial adipose tissue in patients with coronary heart disease and visceral obesity by Dyleva, Y A, Gruzdeva, O V, Uchasova, E G, Borodkina, D A, Belik, E V, Kokov, A N, Brel, N K, Pecherina, T B, Kashtalap, V V, Karetnikova, V N, Barbarash, O L

“…Abstract Purpose Study of the effect of epicardial adipose tissue and in serum collagen in patients with myocardial infarction depending on the presence of…”
Get full text

Clinical case of generalized amyloidosis (ATTR-amyloidosis) with a progressive course of chronic heart failure. Case report by Golubovskaya, D P, Dren', E V, Yurkina, A V, Pecherina, T B, Barbarash, O L

“…Despite the presence of various signs of cardiac amyloidosis ("red flags"), the introduction into routine practice of new non-invasive diagnostic methods…”
Get full text

Practical guidelines for the diagnosis and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM or transthyretin cardiac amyloidosis) by Tereshchenko, Sergey N., Zhirov, Igor V., Moiseeva, Olga M., Adasheva, Tatiana V., Ansheles, Alexey A., Barbarash, Olga L., Galyavich, Albert S., Gudkova, Alexandra Ia, Zateyshchikov, Dmitry A., Kostareva, Anna A., Nasonova, Svetlana N., Nedogoda, Sergey V., Pecherina, Tamara B., Ryzhkova, Daria V., Sergienko, Vladimir B.

“…This paper summarizes the data from updated international protocols and guidelines for diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM). The…”
Get full text

ASSOCIATIONS OF EPICARDIAL FAT THICKNESS AND CIRCULATING MARKERS OF MYOCARDIAL FIBROSIS IN PATIENTS WITH MYOCARDIAL INFARCTION by E. V. Belik, O. V. Gruzdeva, Yu. A. Dileva, D. A. Borodkina, N. K. Brel, E. E. Bychkova, T. B. Pecherina, V. N. Karetnikova, V. V. Kashtalap, E. I. Palicheva, A. A. Kuzmina, E. V. Fanaskova, O. L. Barbarash

“…Aim: to determine the association of the thickness of epicardial adipose tissue (EAT) with the level of biological markers and the degree of myocardial…”
Get full text

CLINICAL SIGNIFICANCE AND DYNAMICS OF BIOMARKERS OF MYOCARDIAL REMODELING IN PATIENTS WITH ST SEGMENT ELEVATION MYOCARDIAL INFARCTION AND PRESERVED LEFT VENTRICULAR FUNCTION by T. B. Pecherina, N. V. Fedorova, A. I. German, A. G. Chernobay, T. P. Solodilova, V. N. Karetnikova, O. V. Gruzdeva, O. M. Polikutina, V. V. Kashtalap, O. L. Barbarash

“…Objective: to determine the clinical significance of markers of myocardial remodeling (NT-proBNP, galectin-3, sST2, MMP-1, 2, 3 and TIMP-1) in patients with ST…”
Get full text